When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety
Human Reproduction Open · 12.03.2026 · 2026 (2)
DOI: 10.1093/hropen/hoag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction Open, online erschienen am 18.03.2026. Verfasst von Yeyi Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
- Center for Upstream Prevention of Adiposity and Diabetes Mellitus (UPSTREAM), Pleasanton, CA, USA.
ORCID-Profile: Yeyi Zhu
Zitieren
APA
Zhu, Y., & Hedderson, M. M. (2026). When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety. Human Reproduction Open, 2026(2). https://doi.org/10.1093/hropen/hoag016
Vancouver
Zhu Y, Hedderson MM. When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety. Human Reproduction Open. 2026;2026(2). doi:10.1093/hropen/hoag016
BibTeX
@article{Zhu2026,
author = {Zhu, Yeyi and Hedderson, Monique M},
title = {When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety},
journal = {Human Reproduction Open},
year = {2026},
volume = {2026},
number = {2},
doi = {10.1093/hropen/hoag016}
}
EUVIMED